Long-term safety of total knee arthroplasty in patients with chronic kidney disease in Taiwan: a retrospective cohort study. 2024

Chun-Ru Lin, and Chune-Chen Lee, and Yu-Feng Kuo, and Shih-Pei Huang, and Yong-Chen Chen, and Shu-Hao Chang
Department of Orthopedics, Chang Gung Memorial Hospital, Chang Gung University, No. 5, Fuxing St., Guishan Dist., Taoyuan City 333423, (R.O.C.), Taiwan.

BACKGROUND Chronic kidney disease (CKD) is a prevalent condition in Taiwan, and the incidence of total knee arthroplasty (TKA) is on the rise. This study aimed to evaluate the postoperative results of patients with different degrees of CKD after TKA, using data from the Taiwan National Health Insurance Research Database. METHODS The study analyzed 3,078 patients who received TKA from 2012 to 2017, equally divided into three groups: none-CKD, mild CKD (without dialysis), and severe CKD (with dialysis). Propensity score matching was used to minimize selection bias. RESULTS After TKA, there was no significant difference in the risk of debridement surgery for infection between the three groups (adjusted HR of mild CKD 0.71 95% CI = 0.36 - 1.38, P = 0.3073; adjusted HR of severe CKD: 1.14, 95% CI = 0.63 - 2.06, P = 0.6616). However, CKD patients requiring dialysis had a significantly higher risk of mortality (adjusted HR 1.98, 95% CI = 1.57 - 2.50, P < 0.001) and readmission within 90 days of any causes (adjusted HR 1.83, 95% CI = 1.48 - 2.26, P < 0.001) than non-CKD and mild CKD patients. CONCLUSIONS Severe CKD patients needing dialysis after TKA have a higher risk of mortality and readmission rates than that of the non-CKD or mild CKD patients. If the patient is in the early stage of CKD, their prognosis after receiving TKA is expected to be as good as non-CKD patients. METHODS IV; well-designed cohort study.

UI MeSH Term Description Entries

Related Publications

Chun-Ru Lin, and Chune-Chen Lee, and Yu-Feng Kuo, and Shih-Pei Huang, and Yong-Chen Chen, and Shu-Hao Chang
January 2018, Frontiers in pharmacology,
Chun-Ru Lin, and Chune-Chen Lee, and Yu-Feng Kuo, and Shih-Pei Huang, and Yong-Chen Chen, and Shu-Hao Chang
November 2022, BMC surgery,
Chun-Ru Lin, and Chune-Chen Lee, and Yu-Feng Kuo, and Shih-Pei Huang, and Yong-Chen Chen, and Shu-Hao Chang
March 2017, The Journal of arthroplasty,
Chun-Ru Lin, and Chune-Chen Lee, and Yu-Feng Kuo, and Shih-Pei Huang, and Yong-Chen Chen, and Shu-Hao Chang
July 2008, Haemophilia : the official journal of the World Federation of Hemophilia,
Chun-Ru Lin, and Chune-Chen Lee, and Yu-Feng Kuo, and Shih-Pei Huang, and Yong-Chen Chen, and Shu-Hao Chang
January 2023, Expert review of pharmacoeconomics & outcomes research,
Chun-Ru Lin, and Chune-Chen Lee, and Yu-Feng Kuo, and Shih-Pei Huang, and Yong-Chen Chen, and Shu-Hao Chang
October 2017, Journal of orthopaedic surgery and research,
Chun-Ru Lin, and Chune-Chen Lee, and Yu-Feng Kuo, and Shih-Pei Huang, and Yong-Chen Chen, and Shu-Hao Chang
July 2020, Journal of clinical orthopaedics and trauma,
Chun-Ru Lin, and Chune-Chen Lee, and Yu-Feng Kuo, and Shih-Pei Huang, and Yong-Chen Chen, and Shu-Hao Chang
January 2021, Regional anesthesia and pain medicine,
Chun-Ru Lin, and Chune-Chen Lee, and Yu-Feng Kuo, and Shih-Pei Huang, and Yong-Chen Chen, and Shu-Hao Chang
November 2021, BMC musculoskeletal disorders,
Chun-Ru Lin, and Chune-Chen Lee, and Yu-Feng Kuo, and Shih-Pei Huang, and Yong-Chen Chen, and Shu-Hao Chang
August 2023, BMC musculoskeletal disorders,
Copied contents to your clipboard!